
WHAT IS ONAPGOTM?
The first and only wearable apomorphine infusion device for people with Parkinson's disease (PD)
ONAPGO is for the continuous treatment of OFF episodes in people with Parkinson’s disease (PD) that are not adequately controlled with oral levodopa and one or more PD medications. Discover what’s possible with ONAPGO.
CONTINUOUS
Help smooth the ups and downs in your day
ONAPGO provides a constant delivery of apomorphine through a wearable infusion device that is generally worn all day.

Wearable device applied just under the skin (subcutaneous), similar to insulin devices

About the size and weight of an average smartphone
CONSISTENT
Help make your days with Parkinson's more predictable with less OFF time
In a clinical trial, patients experienced:
Less daily OFF time with ONAPGO
(primary endpoint)

2.6 HOURS/DAY
VS 0.9 HOURS/DAY
WITH PLACEBO
OFF time = when PD symptoms are not adequately controlled with oral levodopa and can disrupt your day-to-day life.
More GOOD ON time each day
(key secondary endpoint)

2.8 HOURS/DAY
VS 1.1 HOURS/DAY
WITH PLACEBO
GOOD ON time = when you are not experiencing motor symptoms or bothersome dyskinesia.
Study design: The main objective of the ONAPGO clinical study was to evaluate efficacy and safety in people with PD with unsatisfactory control of motor fluctuations despite treatment with oral levodopa and one or more other PD medications. 53 patients received ONAPGO and 54 patients received placebo for 12 weeks. Efficacy was assessed from the start of the study to the end at 12 weeks. The primary measure was the average change in total daily OFF time based on patient diaries. Key secondary efficacy measures included average change in total daily ON time without troublesome dyskinesia.
SAFETY INFORMATION
The most common side effects in the ONAPGO 12-week clinical trial were:
- Infusion site bump
- Nausea
- Sleepiness
- Infusion site redness
- Dyskinesia
- Headache
- Insomnia
ONAPGO can cause serious side effects, including:
- Allergic reaction
- Blood clots
- Nausea and vomiting
- Sleepiness or falling asleep during the day
- Dizziness
- Falls
- Hallucinations or psychotic-like behavior
- Sudden uncontrolled movements (dyskinesia)
- Low red blood cells (hemolytic anemia)
- Strong (intense) urges
- Heart problems
- Serious heart rhythm changes (QT prolongation)
- Fever and confusion
- Tissue changes (fibrotic complications)
Circle of CareTM Program
For the entire time you’re on ONAPGO, you and your care partner will receive ongoing comprehensive support.

Clinical Educators are licensed and experienced nurses who provide personalized help with starting ONAPGO, setting up and wearing the device, collaborating with your doctor, and more.

Circle of Care Coordinators can assist with insurance coverage, assistance programs, and answer any questions. They'll also work with your doctor's office and specialty pharmacy for medication delivery.
Call 1-833-3-ONAPGO or 1-833-366-2746 for more information